PlainRecalls
FDA Drug Moderate Class II Terminated

Epinephrine Injection, USP, Single-Dose Auto-Injectors 0.3 mg, packaged in 2 count carton, Rx only, MFG: Mylan Pharma, NDC 49502-102-02

Reported: June 15, 2022 Initiated: April 13, 2022 #D-1013-2022

Product Description

Epinephrine Injection, USP, Single-Dose Auto-Injectors 0.3 mg, packaged in 2 count carton, Rx only, MFG: Mylan Pharma, NDC 49502-102-02

Reason for Recall

cGMP deviations: Temperature abuse

Details

Units Affected
55 packs
Distribution
USA nationwide.
Location
Richmond, VA

Frequently Asked Questions

What product was recalled?
Epinephrine Injection, USP, Single-Dose Auto-Injectors 0.3 mg, packaged in 2 count carton, Rx only, MFG: Mylan Pharma, NDC 49502-102-02. Recalled by Mckesson Medical-Surgical Inc. Corporate Office. Units affected: 55 packs.
Why was this product recalled?
cGMP deviations: Temperature abuse
Which agency issued this recall?
This recall was issued by the FDA Drug on June 15, 2022. Severity: Moderate. Recall number: D-1013-2022.